Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01606618
Other study ID # B110797-30
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date March 12, 2012
Est. completion date September 11, 2017

Study information

Verified date April 2021
Source Rennes University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

With improved life expectancy over the last fifty years, spina bifida has become a disease of the adult. One of the major stakes for these patients is the preservation of a regular follow-up of uro-nephrologicals risk factors and of a respect for the rules of self management of their neurological bladder. The main objective of this study is to highlight a difference in the level of global self-esteem among a population of adult patients with spina bifida and a population of adult patients with traumatic spinal cord injury gained the same level of neurological.


Description:

With improved life expectancy over the last fifty years, spina bifida has become a disease of the adult. The risk of developing a terminal renal insufficiency is eight times higher than the risk in the general population and twice as important as in acquired spinal cord injury. This risk continues to evolve with advancing age. One of the major stakes for these patients is the preservation of a regular follow-up of uro-nephrologicals risk factors and of a respect for the rules of self management of their neurological bladder. However, some studies report that nearly two thirds of these patients are not monitored at regular neuro-urological in the adulthood. Different psychosocial determinants were analyzed as potential markers of the impact of chronic diseases from childhood to adulthood and could account for the disparity of follow-up and access to healthcare. Among these, the self-esteem is a psychological dimension of analysis particularly relevant within the framework of chronic states inherited from the childhood. The investigators formulate the hypothesis that global self-esteem and lower perceived self-efficacy may be a causal predictive factor of a reduced access to the continence and a lower compliance monitoring in adult patients with a spina bifida.


Recruitment information / eligibility

Status Terminated
Enrollment 111
Est. completion date September 11, 2017
Est. primary completion date September 11, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Patients with a spina bifida aperta or an acquired traumatic spinal cord injury dating more than two years, the level of injury being below D12 and higher S1 (Score ASIA A). - Age between 18 and 60 - Knowing how to read, write, count - Having given their free, informed and in writing consent (an information is also given to the reliable person when it exists) - Affiliated to the National Health Service Exclusion Criteria: - Psychiatric history requiring an hospitalization in a specialized unit during more than two months - Score MMS lower than 27 ( GRECO version) - Serious associated pathology or associated pathology which could interfer with the management of vesico-sphincteral disorders - Neurosurgery, dating from less than one year - Symptoms of dysfunction of ventricular bypass valve at the time of inclusion - Clinical epileptic attack within six months prior to inclusion - Pregnancy or breastfeeding - Simultaneous inclusion in an another therapeutic protocol or period of exclusion from an another protocol - Traumatic spinal cord injury acquired before age 16

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France CHU de Besançon Besançon
France Clinique Saint Augustin Bordeaux
France CHU de Lille Lille
France Urologie CH Lyon Sud et Hôpital Henry Gabrielle Lyon
France APHM - Hôpital de la Conception Service de chirurgie urologique et transplantation rénale Marseille
France MPR neurologique CHU de Nantes Nantes
France APHP Raymond Poincaré Paris
France APHP Rothschild Paris
France Neuro-urologie et explorations périnéales, APHP Tenon Paris
France Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de KERPAPE Ploemeur
France CHU de Rennes CR Spina bifida Rennes
France Hôpital Pontchaillou - CHU de Rennes Rennes
France MPR St Hélier Rennes
France Urologie, CHU de Rouen Rouen
France MPR CHU Rangueuil Toulouse
France Urologie CHU Rangueuil Toulouse Toulouse

Sponsors (1)

Lead Sponsor Collaborator
Rennes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measure of the global self-esteem by the Rosenberg scale (RSES) Score range : 10 - 40. High scores indicate hight self esteem. At day 0
Secondary Evaluation of depression and anxiety by Hamilton's scale (HAD) Score range : 0 - 21. High scores indicate a hight level of symptoms. At day 0, at month 6
Secondary Neuropsychological evaluation (WAIS-III battery composite GREFEX, CVLT) Battery of test exploring executives functions. High scores indicate high level of executive functions. At day 0
Secondary Rating Scale vesico-sphincter and anorectal function (ISCOS) High scores indicate high vesico-sphincter and anorectal dysfunction At day 0, at month 6
Secondary Evaluation scale for the achievement of self catheterizing 14 binary items At day 0, at month 6
Secondary Scale functional mobility and transfers (SCIM III) The SCIM is a disability scale in order to describe patients' ability to accomplish activities of daily living and to make functional assessments of this population more sensitive to changes.
SCIM-III is comprised of 19 items in 3 subscales, which are:
(i) self-care (sub-score 0-20); (ii) respiration and sphincter management (sub-score 0-40); (iii) mobility (sub-score 0-40). The mobility subscale is further sub-divided to assess mobility "in room and toilet" and for "indoors and outdoors, on an even surface".
The total score ranges from 0 to 100.
At day 0
Secondary Measure of the global self-esteem by the Rosenberg scale (RSES) Score range : 10 - 40. High scores indicate hight self esteem. At month 6
Secondary Observance of the appointment At month 6
Secondary Observance of holding of the mictionnel catalog At month 6
Secondary Measure of auto-efficiency experienced scale for Medullary Injured (MSES) 16 items ranging from 1 to 7
Range 16 - 112
High scores correspond to low level of percieved auto-efficiency
At Day 0